Obtenga las últimas noticias sobre las acciones de Gossamer Bio con actualizaciones sobre las tendencias del mercado, las finanzas y el análisis de Benzinga. Manténgase informado sobre el rendimiento de GOSS

Últimas noticias sobre

GOSSAMER BIO INC

Gossamer Bio

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Gossamer Bio Inc

GOSSAN RESOURCES LTD CDA by Gossan Resources Ltd.

Gossan Resources Ltd

Press Releases

Gossamer Bio Announces Completion of Enrollment in Registrational Phase 3 PROSERA Study for the Treatment of PAH

Gossamer Bio Announces Second Quarter 2025 Financial Results and Provides Business Update

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Gossamer Bio to Present at Upcoming Investor Conferences

Gossamer Bio Announces Presentations at the European Respiratory Society (ERS) Congress 2025

Penny Stocks

Small Cap

Gossamer Bio Enters into Option Agreement to Acquire Respira Therapeutics and Its Lead Candidate, RT234, an Inhaled, On‑Demand Vardenafil for Pulmonary Hypertension

Respira Therapeutics Enters into Agreement with Gossamer Bio (Gossamer) Granting Gossamer Option to Acquire Respira from Samsara BioCapital

News

Presenting on Emerging Growth Conference 87 Day 1 on October 22. Register to live stream.

Presenting on Emerging Growth Conference 87 Day 2 on October 23; Register to live stream

ATCH

CLNN

CMCXF

COPAF

CRVO

CSE:HG

CSE:PHOS

CUAUF

CYBHF

ELRRF

FRSPF

GOSS

HGRAF

IMRN

KBRIF

LGCXF

RGBP

SGGTF

SRGZ

TSX:ELO

TSX:VGZ

TSXV:CCCM

TSXV:CPAU

TSXV:CYBE

TSXV:KRI

TSXV:LG

TSXV:SGU

TSXV:WLR

TSXV:WRLG

WRLGF

Absci

ADC Therapeutics

Akebia Therapeutics

Bicycle Therapeutics plc - American Depositary Shares

Bicycle Therapeutics

COMPASS Pathways Plc - American Depository Shares

Compass Pathways

Compass Therapeutics, Inc. - Common Stock

Compass Therapeutics

Corvus Pharmaceuticals, Inc. - Common Stock

Corvus Pharma

CytomX Therapeutics

DBV Technologies S.A. - American Depositary Shares

DBV Technologies

Emergent BioSolutions

Erasca

4D Molecular Therapeutics, Inc. - Common Stock

4D Molecular Therapeutics

I-MAB

Inventiva S.A. - American Depository Shares

Inventiva

KalVista Pharmaceuticals, Inc. - Common Stock

KalVista Pharmaceuticals

Lexicon Pharmaceuticals, Inc. - Common Stock

Lexicon Pharmaceuticals

MoonLake Immunotherapeutics - Class A Ordinary Shares

MoonLake

Monopar Therapeutics

Ocugen

Olema Pharmaceuticals, Inc. - Common Stock

Olema Pharmaceuticals

Organogenesis Holdings

Prothena Corporation plc - Ordinary Shares

Prothena Corp

Regenxbio

Rigel Pharmaceuticals, Inc. - Common Stock

Rigel Pharmaceuticals

Verastem

Wedbush

Scotiabank

Goldman Sachs

HC Wainwright & Co.

Comments

Gossamer Bio Noticias bursátiles

Noticias

Últimas noticias sobre

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL